semaglutide cardiovascular outcomes study 2025 news SOUL: Oral Bests Usual Care in High-Risk Type 2 Diabetes Novo Nordisk's Wegovy (Semaglutide) Reduces

If nausea limits fluid intake, patients should consult their prescriber about antiemetic medications

Item description Cosmetic Clinical Trials: This study is designed to assess the safety and effectiveness of dermal microcoring to improve: Cheek facial volume loss Skin laxity Moderate facial wrinkles *as a result of GLP-1 weight loss Participants must: Be 22+ y/o Ma le or female Have a history of GLP-1 medication use Experience facial volume loss or wrinkles , particularly in the cheek area Meet additional study eligibility criteria (determined during screening) 18 years old and up Male or Female Moderate to severe wrinkle-like lines that appear between the eyebrows Various injectable treatments in study *Blood work WILL be done in study (provided) More details coming soon

Pharmaceutical companies are also developing new formulations that may be easier to use or have fewer side effects

These medications are expensive and often not covered without a qualifying diagnosis (e.g., BMI threshold or diabetes)

[ 63 , 64 ] This suggests that OGlcNAc signaling may directly influence the ubiquitin system